Statins in heart failure: Retrospective cohort study using routine primary care data

Annals of Medicine

Volumn 41, Issue 7, 2009, Pages 490-496

  Ryan, Ronan P ^a   McManus, Richard J ^a   Mant, Jonathan ^b   MacLeod, John A A ^c   Hobbs, F D Richard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cohort studies; Heart failure; Hydroxymethylglutaryl CoA reductase inhibitors; Survival analysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DEATH; DRUG EFFECT; DRUG EFFICACY; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORBIDITY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; THERAPY EFFECT; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY DISEASE; FEMALE; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349954723     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890903022819     Document Type: Article

References (19)

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995 333 1301-1307
2. Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307
3. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
4. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278
5. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, et al. CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357:2301-.
6. Gissi-HF Investigators; Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231-1239
7. van der Harst P, Voors AA, van Gilst WH, Bohm M, van Veldhuisen DJ. Statins in the treatment of chronic heart failure: a systematic review. PLoS Med. 2006;3:e333.
8. Velagaleti RS, Vasan RS. Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? Cardiol Clin. 2007;25:487-495
9. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171-177
10. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Phar-macoepidemiol Drug Saf. 2007;16:393-01.
11. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136.
12. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002;360:1631-1639
13. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N. Evaluation of the management of heart failure in primary care. Fam Pract. 2009;26:145-153
14. Ray JG, Gong Y, Sykora K, Tu JV. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med. 2005;165:62-67
15. Mant J, Wilson S, Parry J, Bridge P, Wilson R, Murdoch W, et al. Clinicians didn't reliably distinguish between different causes of cardiac death using case histories. J Clin Epidemiol. 2006;59:862-867
16. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207
17. Brady AJB, Norrie J, Ford I. Statin prescribing: is the reality meeting the expectations of primary care? Br J Cardiol. 2005;12:397-00.
18. de Lusignan S, Dzregah B, Hague N, Chan N. Cholesterol management in patients with IHD: an audit-based appraisal of progress towards clinical targets in primary care. Br J Cardiol. 2003;10:223-228
19. Hobbs FD, Southworth H. Achievement of English National Service Framework lipid-lowering goals: pooled data from recent comparative treatment trials of statins at starting doses. Int J Clin Pract. 2005;59:1171-1177